新诊断的高风险多发性骨髓瘤:结果和管理
Fatma Zehra Yasar1, Elan Gorshein2
1Department of Internal Medicine, Marmara University School of Medicine, Istanbul, Turkey.
Advances in hematology
|October 6, 2025
概括
高风险的多发性骨髓瘤 (MM) 治疗正在发展,新的四倍疗法和新兴疗法如CAR-T细胞. 个性化,适应风险的策略是改善患者治疗结果的关键.
科学领域:
- 血液恶性瘤研究研究
- 癌症基因组学和治疗方法
- 临床试验设计 临床试验设计
背景情况:
- 多发性髓瘤 (MM) 是一种复杂的血液癌症,在患有高风险细胞遗传异常 (HRCAs) 的患者中预后较差.
- 包括del{17p},t{4;14},t{14},t{16}和gain{1q}在内的HRCAs影响20%-25%的新诊断的患者,导致侵袭性疾病和降低生存率.
- 目前高风险MM的治疗环境需要不断发展以应对这些挑战.
研究的目的:
- 审查当前和新兴的高风险多发性骨髓瘤治疗策略.
- 检查诱导方案,自身干细胞移植 (ASCT) 的作用,以及巩固/维护疗法.
- 探索将双特异抗体和CAR-T细胞等新型疗法集成到早期治疗线上.
主要方法:
- 对高风险MM的不断变化的治疗场景的文献综述.
- 对可移植和不可移植患者的诱导策略的分析.
- 检查新出现的模式,包括双特异性抗体和CAR-T细胞疗法.
主要成果:
- 四种诱导疗法 (蛋白酶抑制剂,免疫调节药物,单克隆抗体) 显示出改善的结果,并正在成为标准的前线治疗.
- 新兴的双特异性抗体和CAR-T细胞疗法正在研究,以便更早地纳入治疗方案.
- 使用细胞遗传学分析和MRD监测的个性化,与风险相适应的方法具有重大潜力.
结论:
- 高风险多发性骨髓瘤的治疗正在迅速推进,新的四重疗法和创新的免疫疗法.
- 双特异性抗体和CAR-T细胞疗法的早期整合可能会显著改变护理标准.
- 以基因分析和MRD状态为指导的个性化医疗对于优化高风险MM患者的治疗结果至关重要.
更多相关视频
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.5K
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
9.1K
相关概念视频
01:22Myocarditis IV: Nursing Management
205
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
205
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
01:21Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
285
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
285